FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lindsay DeVane

Research Profile

Physiology

Chemicals & Drugs

Disorders

Depressive Disorder

Procedures

High Pressure Liquid Chromatography

Concepts & Ideas

Co-author Network

Publications

TOP 3
Jun-Sheng Wang; Hao-Jie Zhu; Jennifer L Donovan; Hong-Jie Yuan; John S Markowitz; Mark E Geesey; C Lindsay DeVane
Aripiprazole brain concentration is altered in P-glycoprotein deficient mice.
John S Markowitz; C Lindsay DeVane; Sammanda Ramamoorthy; Hao-Jie Zhu
The psychostimulant d-threo-(R,R)-methylphenidate binds as an agonist to the 5HT(1A) receptor.
John E Piletz; Angelos Halaris; Omer Iqbal; Debra Hoppensteadt; Jawed Fareed; He Zhu; James M Sinacore; C Lindsay DeVane
Pro-inflammatory biomakers in depression: treatment with venlafaxine.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lindsay DeVane (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Jun-Sheng Wang; Hao-Jie Zhu; Jennifer L Donovan; Hong-Jie Yuan; John S Markowitz; Mark E Geesey; C Lindsay DeVane
Aripiprazole brain concentration is altered in P-glycoprotein deficient mice.
Schizophrenia research 2009;110(1-3):90-4.
2009: John S Markowitz; C Lindsay DeVane; Sammanda Ramamoorthy; Hao-Jie Zhu
The psychostimulant d-threo-(R,R)-methylphenidate binds as an agonist to the 5HT(1A) receptor.
Die Pharmazie 2009;64(2):123-5.
2009: John E Piletz; Angelos Halaris; Omer Iqbal; Debra Hoppensteadt; Jawed Fareed; He Zhu; James M Sinacore; C Lindsay DeVane
Pro-inflammatory biomakers in depression: treatment with venlafaxine.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2009;10(4):313-23.
2008: Jun-Sheng Wang; Hao-Jie Zhu; John S Markowitz; Jennifer L Donovan; Hong-Jie Yuan; C Lindsay DeVane
Antipsychotic drugs inhibit the function of breast cancer resistance protein.
Basic & clinical pharmacology & toxicology 2008;103(4):336-41.
2008: Hao-Jie Zhu; Kennerly S Patrick; Hong-Jie Yuan; Jun-Sheng Wang; Jennifer L Donovan; C Lindsay DeVane; Robert Malcolm; Julie A Johnson; Geri L Youngblood; Douglas H Sweet; Taimour Y Langaee; Hao-Jie Zhu
Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis.
American journal of human genetics 2008;82(6):1241-8.
2008: Jun-Sheng Wang; Hao-Jie Zhu; Bryan B Gibson; Hao-Jie Zhu; Jennifer L Donovan; C Lindsay DeVane
Sertraline and its metabolite desmethylsertraline, but not bupropion or its three major metabolites, have high affinity for P-glycoprotein.
Biological & pharmaceutical bulletin 2008;31(2):231-4.
2008: Natalie L LeVasseur; Hao-Jie Zhu; John S Markowitz; C Lindsay DeVane; Kennerly S Patrick
Enantiospecific gas chromatographic-mass spectrometric analysis of urinary methylphenidate: implications for phenotyping.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2008;862(1-2):140-9.
2008: Hao-Jie Zhu; Jun-Sheng Wang; Jennifer L Donovan; Yan Jiang; Bryan B Gibson; C Lindsay DeVane; Hao-Jie Zhu
Interactions of attention-deficit/hyperactivity disorder therapeutic agents with the efflux transporter P-glycoprotein.
European journal of pharmacology 2008;578(2-3):148-58.
2007: Hao-Jie Zhu; Jun-Sheng Wang; Kennerly S Patrick; Jennifer L Donovan; C Lindsay DeVane; Hao-Jie Zhu
A novel HPLC fluorescence method for the quantification of methylphenidate in human plasma.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2007;858(1-2):91-5.
2007: Helen R Winter; C Lindsay DeVane; Carlos Figueroa; Debra J Ennis; Jennifer E Hamer-Maansson; Patty C Davis; Mark A Smith
Open-label steady-state pharmacokinetic drug interaction study on co-administered quetiapine fumarate and divalproex sodium in patients with schizophrenia, schizoaffective disorder, or bipolar disorder.
Human psychopharmacology 2007;22(7):469-76.
2007: D Jeffrey Newport; Martha R Calamaras; C Lindsay DeVane; Jennifer L Donovan; Aquila J Beach; Stephanie Winn; Bettina T Knight; Bryan B Gibson; Adele C Viguera; Michael J Owens; Charles Nemeroff; Zachary N Stowe
Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes.
The American journal of psychiatry 2007;164(8):1214-20.
2007: S Craig Risch; Michael David Horner; Susan R McGurk; Simmy Palecko; John S Markowitz; Ziad Nahas; C Lindsay DeVane
Double-blind donepezil-placebo crossover augmentation study of atypical antipsychotics in chronic, stable schizophrenia: a pilot study.
Schizophrenia research 2007;93(1-3):131-5.
2007: Charles Nemeroff; Sheldon H Preskorn; C Lindsay DeVane
Antidepressant drug-drug interactions: clinical relevance and risk management.
CNS spectrums 2007;12(5 Suppl 7):1-13.
2007: Hao-Jie Zhu; Jun-Sheng Wang; Hao-Jie Zhu; Jennifer L Donovan; Bryan B Gibson; C Lindsay DeVane
Risperidone and paliperidone inhibit p-glycoprotein activity in vitro.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2007;32(4):757-64.
2007: Kennerly S Patrick; Arthur B Straughn; R R Minhinnett; Sharon D. Yeatts; Amy E Herrin; C Lindsay DeVane; Robert Malcolm; G C Janis; John S Markowitz
Influence of ethanol and gender on methylphenidate pharmacokinetics and pharmacodynamics.
Clinical pharmacology and therapeutics 2007;81(3):346-53.
2007: Hao-Jie Zhu; Jun-Sheng Wang; Jennifer L Donovan; C Lindsay DeVane; Bryan B Gibson; Hao-Jie Zhu
Sensitive quantification of atomoxetine in human plasma by HPLC with fluorescence detection using 4-(4,5-diphenyl-1H-imidazole-2-yl) benzoyl chloride derivatization.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2007;846(1-2):351-4.
2007: Jun-Sheng Wang; D Jeffrey Newport; Zachary N Stowe; Jennifer L Donovan; Page B Pennell; C Lindsay DeVane
The emerging importance of transporter proteins in the psychopharmacological treatment of the pregnant patient.
Drug metabolism reviews 2007;39(4):723-46.
2006: John S Markowitz; C Lindsay DeVane; Linda Pestreich; Kennerly S Patrick; Rafael Muniz
A comprehensive in vitro screening of d-, l-, and dl-threo-methylphenidate: an exploratory study.
Journal of child and adolescent psychopharmacology 2006;16(6):687-98.
2006: S Craig Risch; Michael David Horner; Susan R McGurk; Simmy Palecko; John S Markowitz; Ziad Nahas; C Lindsay DeVane
Donepezil effects on mood in patients with schizophrenia and schizoaffective disorder.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2006;9(5):603-5.
2006: Jun-Sheng Wang; Hao-Jie Zhu; Hao-Jie Zhu; Jennifer L Donovan; C Lindsay DeVane
Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein.
Psychopharmacology 2006;187(4):415-23.
2006: C Lindsay DeVane
Antidepressant-drug interactions are potentially but rarely clinically significant.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(8):1594-604; discussion 1614-5.
2006: C Lindsay DeVane; Zachary N Stowe; Jennifer L Donovan; D Jeffrey Newport; Page B Pennell; James C Ritchie; Michael J Owens; Jun-Sheng Wang
Therapeutic drug monitoring of psychoactive drugs during pregnancy in the genomic era: challenges and opportunities.
Journal of psychopharmacology (Oxford, England) 2006;20(4 Suppl):54-9.
2006: Hao-Jie Zhu; Jun-Sheng Wang; C Lindsay DeVane; Robin L Williard; Jennifer L Donovan; Lawrence D Middaugh; Bryan B Gibson; Kennerly S Patrick; Hao-Jie Zhu
The role of the polymorphic efflux transporter P-glycoprotein on the brain accumulation of d-methylphenidate and d-amphetamine.
Drug metabolism and disposition: the biological fate of chemicals 2006;34(7):1116-21.
2006: Hao-Jie Zhu; Jun-Sheng Wang; Hao-Jie Zhu; Jennifer L Donovan; Bryan B Gibson; Holly A Gefroh; C Lindsay DeVane
Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana.
The Journal of pharmacology and experimental therapeutics 2006;317(2):850-7.
2006: Hao-Jie Zhu; C Lindsay DeVane; Robert Malcolm; Holly A Gefroh; Jun-Sheng Wang; Hao-Jie Zhu; Jennifer L Donovan
Pharmacokinetics of olanzapine after single-dose oral administration of standard tablet versus normal and sublingual administration of an orally disintegrating tablet in normal volunteers.
Journal of clinical pharmacology 2006;46(2):164-71.
2006: Ada M Loughhead; Zachary N Stowe; D Jeffrey Newport; James C Ritchie; C Lindsay DeVane; Michael J Owens
Placental passage of tricyclic antidepressants.
Biological psychiatry 2006;59(3):287-90.
2006: Robert Malcolm; Karla Swayngim; Jennifer L Donovan; C Lindsay DeVane; Ahmed Elkashef; Nora Chiang; Roberta Khan; Jurij Mojsiak; Donald L. Myrick; Sarra Hedden; Kristi Cochran; Robert F Woolson
Modafinil and cocaine interactions.
The American journal of drug and alcohol abuse 2006;32(4):577-87.
2006: Ada M Loughhead; Angela D Fisher; D Jeffrey Newport; James C Ritchie; Michael J Owens; C Lindsay DeVane; Zachary N Stowe
Antidepressants in amniotic fluid: another route of fetal exposure.
The American journal of psychiatry 2006;163(1):145-7.
2006: Jun-Sheng Wang; C Lindsay DeVane; Bryan B Gibson; Jennifer L Donovan; Hao-Jie Zhu; Hao-Jie Zhu
Population pharmacokinetic analysis of drug-drug interactions among risperidone, bupropion, and sertraline in CF1 mice.
Psychopharmacology 2006;183(4):490-9.
2005: C Lindsay DeVane
Fluvoxamine.
Neuropsychiatric disease and treatment 2005;1(4):287.
2005: Jennifer L Donovan; C Lindsay DeVane; John G Lewis; Jun-Sheng Wang; Ying Ruan; Kenneth D Chavin; John S Markowitz
Effects of St John's wort (Hypericum perforatum L.) extract on plasma androgen concentrations in healthy men and women: a pilot study.
Phytotherapy research : PTR 2005;19(10):901-6.
2005: Jennifer L Donovan; C Lindsay DeVane; Kenneth D Chavin; Jim Oates; Chinedu J Njoku; Kennerly S Patrick; Ryan N Fiorini; John S Markowitz
Oral administration of a decaffeinated green tea (Camellia sinensis) extract did not alter urinary 8-epi-prostaglandin F(2 alpha), a biomarker for in-vivo lipid peroxidation.
The Journal of pharmacy and pharmacology 2005;57(10):1365-9.
2005: C Lindsay DeVane; Evelyn Chiao; Meg Franklin; Eric J Kruep
Anxiety disorders in the 21st century: status, challenges, opportunities, and comorbidity with depression.
The American journal of managed care 2005;11(12 Suppl):S344-53.
2005: John S Markowitz; C Lindsay DeVane; John G Lewis; Kenneth D Chavin; Jun-Sheng Wang; Jennifer L Donovan
Effect of Ginkgo biloba extract on plasma steroid concentrations in healthy volunteers: a pilot study.
Pharmacotherapy 2005;25(10):1337-40.
2005: Jun-Sheng Wang; John S Markowitz; Jennifer L Donovan; C Lindsay DeVane
P-glycoprotein does not actively transport nicotine and cotinine.
Addiction biology 2005;10(2):127-9.
2005: Jennifer L Donovan; C Lindsay DeVane; Robert Malcolm; Jurij Mojsiak; C Nora Chiang; Ahmed Elkashef; Robin M Taylor
Modafinil influences the pharmacokinetics of intravenous cocaine in healthy cocaine-dependent volunteers.
Clinical pharmacokinetics 2005;44(7):753-65.
2004: Jun-Sheng Wang; Ying Ruan; Robin M Taylor; Jennifer L Donovan; John S Markowitz; C Lindsay DeVane
The brain entry of risperidone and 9-hydroxyrisperidone is greatly limited by P-glycoprotein.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2004;7(4):415-9.
2004: Jennifer L Donovan; C Lindsay DeVane; Kenneth D Chavin; Jun-Sheng Wang; Bryan B Gibson; Holly A Gefroh; John S Markowitz
Multiple night-time doses of valerian (Valeriana officinalis) had minimal effects on CYP3A4 activity and no effect on CYP2D6 activity in healthy volunteers.
Drug metabolism and disposition: the biological fate of chemicals 2004;32(12):1333-6.
2004: Jennifer L Donovan; Kenneth D Chavin; C Lindsay DeVane; Robin M Taylor; Jun-Sheng Wang; Ying Ruan; John S Markowitz
Green tea (Camellia sinensis) extract does not alter cytochrome p450 3A4 or 2D6 activity in healthy volunteers.
Drug metabolism and disposition: the biological fate of chemicals 2004;32(9):906-8.
2004: John S Markowitz; Jennifer L Donovan; C Lindsay DeVane; Kenneth D Chavin
Common herbal supplements did not produce false-positive results on urine drug screens analyzed by enzyme immunoassay.
Journal of analytical toxicology 2004;28(4):272-3.
2004: Jun-Sheng Wang; Ying Ruan; Robin M Taylor; Jennifer L Donovan; John S Markowitz; C Lindsay DeVane
Brain penetration of methadone (R)- and (S)-enantiomers is greatly increased by P-glycoprotein deficiency in the blood-brain barrier of Abcb1a gene knockout mice.
Psychopharmacology 2004;173(1-2):132-8.
2004: C Lindsay DeVane; Jennifer L Donovan; Heidi L Liston; John S Markowitz; Kenneth T Cheng; S Craig Risch; Lauren Willard
Comparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteers.
Journal of clinical psychopharmacology 2004;24(1):4-10.
2003: Hao-Jie Zhu; Jennifer L Donovan; C Lindsay DeVane; Robin M Taylor; Ying Ruan; Jun-Sheng Wang; Kenneth D Chavin
Multiple doses of saw palmetto (Serenoa repens) did not alter cytochrome P450 2D6 and 3A4 activity in normal volunteers.
Clinical pharmacology and therapeutics 2003;74(6):536-42.
2003: John S Markowitz; Jennifer L Donovan; C Lindsay DeVane; Robin M Taylor; Ying Ruan; Jun-Sheng Wang; Kenneth D Chavin
Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme.
JAMA : the journal of the American Medical Association 2003;290(11):1500-4.
2003: John S Markowitz; C Lindsay DeVane; Kenneth D Chavin; Robin M Taylor; Ying Ruan; Jennifer L Donovan
Effects of garlic (Allium sativum L.) supplementation on cytochrome P450 2D6 and 3A4 activity in healthy volunteers.
Clinical pharmacology and therapeutics 2003;74(2):170-7.
2003: Jennifer L Donovan; C Lindsay DeVane; David W Boulton; Seetal Dodd; John S Markowitz
Dietary levels of quinine in tonic water do not inhibit CYP2D6 in vivo.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 2003;41(8):1199-201.
2003: Jun-Sheng Wang; C Lindsay DeVane
Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitro.
Drug metabolism and disposition: the biological fate of chemicals 2003;31(6):742-7.
2003: Jennifer L Donovan; C Lindsay DeVane; Kenneth D Chavin; Robin M Taylor; John S Markowitz
Siberian ginseng (Eleutheroccus senticosus) effects on CYP2D6 and CYP3A4 activity in normal volunteers.
Drug metabolism and disposition: the biological fate of chemicals 2003;31(5):519-22.
2003: Jennifer L Donovan; Robert Malcolm; John S Markowitz; C Lindsay DeVane
Chiral analysis of d- and l-modafinil in human serum: application to human pharmacokinetic studies.
Therapeutic drug monitoring 2003;25(2):197-202.
2003: Federica Azzimonti; Daniel H Atchley; Catherine Anne Morrison; Seetal Dodd; David W Boulton; C Lindsay DeVane; Philippe Arnaud
One step purification of alpha(1)-acid glycoprotein from human plasma. Fractionation of its polymorphic allele products.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2003;784(1):33-8.
2003: C Lindsay DeVane; Jacobo E Mintzer
Risperidone in the management of psychiatric and neurodegenerative disease in the elderly: an update.
Psychopharmacology bulletin 2003;37(4):116-32.
2003: C Lindsay DeVane
Immediate-release versus controlled-release formulations: pharmacokinetics of newer antidepressants in relation to nausea.
The Journal of clinical psychiatry 2003;64 Suppl 18():14-9.
2003: C Lindsay DeVane
Pharmacokinetics, drug interactions, and tolerability of valproate.
Psychopharmacology bulletin 2003;37 Suppl 2():25-42.
2003: C Lindsay DeVane
Pharmacokinetics, drug interactions, and tolerability of paroxetine and paroxetine CR.
Psychopharmacology bulletin 2003;37 Suppl 1():29-41.
2003: Jun-Sheng Wang; C Lindsay DeVane
Pharmacokinetics and drug interactions of the sedative hypnotics.
Psychopharmacology bulletin 2003;37(1):10-29.
2003: John S Markowitz; Arthur B Straughn; Kennerly S Patrick; C Lindsay DeVane; Linda Pestreich; James Lee; Yanfeng Wang; Rafael Muniz
Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.
Clinical pharmacokinetics 2003;42(4):393-401.
2002: David W Boulton; C Lindsay DeVane; Heidi L Liston; John S Markowitz
In vitro P-glycoprotein affinity for atypical and conventional antipsychotics.
Life sciences 2002;71(2):163-9.
2002: C Lindsay DeVane; David W Boulton
Great expectations in stereochemistry: focus on antidepressants.
CNS spectrums 2002;7(4 Suppl 1):28-33.
2002: Heidi L Liston; C Lindsay DeVane; David W Boulton; S Craig Risch; John S Markowitz; Juliet Goldman
Differential time course of cytochrome P450 2D6 enzyme inhibition by fluoxetine, sertraline, and paroxetine in healthy volunteers.
Journal of clinical psychopharmacology 2002;22(2):169-73.
2002: C Lindsay DeVane
Clinical significance of drug binding, protein binding, and binding displacement drug interactions.
Psychopharmacology bulletin 2002;36(3):5-21.
2002: C Lindsay DeVane; Heidi L Liston; John S Markowitz
Clinical pharmacokinetics of sertraline.
Clinical pharmacokinetics 2002;41(15):1247-66.
2002: C Lindsay DeVane; John S Markowitz
Psychoactive drug interactions with pharmacotherapy for diabetes.
Psychopharmacology bulletin 2002;36(2):40-52.
2002: C Lindsay DeVane; Dale R Grothe; Sherry L Smith
Pharmacology of antidepressants: focus on nefazodone.
The Journal of clinical psychiatry 2002;63 Suppl 1():10-7.
2002: John S Markowitz; C Lindsay DeVane; Heidi L Liston; David W Boulton; S Craig Risch
The effects of probenecid on the disposition of risperidone and olanzapine in healthy volunteers.
Clinical pharmacology and therapeutics 2002;71(1):30-8.
2002: John S Markowitz; C Lindsay DeVane; David W Boulton; Heidi L Liston; S Craig Risch
Hypotension and bradycardia in a healthy volunteer following a single 5 mg dose of olanzapine.
Journal of clinical pharmacology 2002;42(1):104-6.
2001: John S Markowitz; CH Kellner; C Lindsay DeVane; MD Beale; JW Folk; Carol Burns; Heidi L Liston
Intranasal sumatriptan in post-ECT headache: results of an open-label trial.
The journal of ECT 2001;17(4):280-3.
2001: Heidi L Liston; John S Markowitz; C Lindsay DeVane
Drug glucuronidation in clinical psychopharmacology.
Journal of clinical psychopharmacology 2001;21(5):500-15.
2001: C Lindsay DeVane
Substance P: a new era, a new role.
Pharmacotherapy 2001;21(9):1061-9.
2001: David W Boulton; John S Markowitz; C Lindsay DeVane
A high-performance liquid chromatography assay with ultraviolet detection for olanzapine in human plasma and urine.
Journal of chromatography. B, Biomedical sciences and applications 2001;759(2):319-23.
2001: C Lindsay DeVane; Charles Nemeroff
An evaluation of risperidone drug interactions.
Journal of clinical psychopharmacology 2001;21(4):408-16.
2001: Heidi L Liston; John S Markowitz; Noel M. Hunt; C Lindsay DeVane; David W Boulton; E Ashcraft
Lack of citalopram effect on the pharmacokinetics of cyclosporine.
Psychosomatics 2001;42(4):370-2.
2001: David W Boulton; Philippe Arnaud; C Lindsay DeVane
Pharmacokinetics and pharmacodynamics of methadone enantiomers after a single oral dose of racemate.
Clinical pharmacology and therapeutics 2001;70(1):48-57.
2001: David W Boulton; Philippe Arnaud; C Lindsay DeVane
A single dose of methadone inhibits cytochrome P-4503A activity in healthy volunteers as assessed by the urinary cortisol ratio.
British journal of clinical pharmacology 2001;51(4):350-4.
2001: Gary M Levin; L A Nelson; C Lindsay DeVane; S L Preston; George Eisele; Stanley W Carson
A pharmacokinetic drug-drug interaction study of venlafaxine and indinavir.
Psychopharmacology bulletin 2001;35(2):62-71.
2001: C Lindsay DeVane; John S Markowitz; Heidi L Liston; S Craig Risch
Charleston Antidepressant Drug Interactions Surveillance Program (CADISP).
Psychopharmacology bulletin 2001;35(2):50-61.
2001: Jennifer L Donovan; C Lindsay DeVane
A primer on caffeine pharmacology and its drug interactions in clinical psychopharmacology.
Psychopharmacology bulletin 2001;35(3):30-48.
2001: John S Markowitz; C Lindsay DeVane
The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum).
Psychopharmacology bulletin 2001;35(1):53-64.
2001: C Lindsay DeVane; Heidi L Liston
An explanation of the second-dose effect in pharmacokinetics and its meaning for clinical psychopharmacology.
Psychopharmacology bulletin 2001;35(1):42-52.
2001: C Lindsay DeVane; Charles Nemeroff
Clinical pharmacokinetics of quetiapine: an atypical antipsychotic.
Clinical pharmacokinetics 2001;40(7):509-22.
2001: S Craig Risch; Susan R McGurk; Michael David Horner; Ziad Nahas; S D Owens; M Molloy; C Gilliard; S Christie; John S Markowitz; C Lindsay DeVane; Jacobo E Mintzer; Mark Stork George
A double-blind placebo-controlled case study of the use of donepezil to improve cognition in a schizoaffective disorder patient: functional MRI correlates.
Neurocase 2001;7(2):105-10.
2000: John S Markowitz; C Lindsay DeVane; Heidi L Liston; S A Montgomery
An assessment of selective serotonin reuptake inhibitor discontinuation symptoms with citalopram.
International clinical psychopharmacology 2000;15(6):329-33.
2000: C Lindsay DeVane
Interaction potential of selective serotonin-reuptake inhibitors.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2000;57(19):1802-3.
2000: David W Boulton; C Lindsay DeVane
Development and application of a chiral high performance liquid chromatography assay for pharmacokinetic studies of methadone.
Chirality 2000;12(9):681-7.
2000: PJ Goodnick; K Breakstone; Adarsh M Kumar; BV Freund; C Lindsay DeVane
Nefazodone in diabetic neuropathy: response and biology.
Psychosomatic medicine 2000;62(4):599-600.
2000: C Lindsay DeVane; John S Markowitz; SW Carson; David W Boulton; H S Gill; Ziad Nahas; S Craig Risch
Single-dose pharmacokinetics of methylphenidate in CYP2D6 extensive and poor metabolizers.
Journal of clinical psychopharmacology 2000;20(3):347-9.
2000: John S Markowitz; C Lindsay DeVane; David W Boulton; Ziad Nahas; S Craig Risch; F Diamond; Kennerly S Patrick
Ethylphenidate formation in human subjects after the administration of a single dose of methylphenidate and ethanol.
Drug metabolism and disposition: the biological fate of chemicals 2000;28(6):620-4.
2000: PJ Goodnick; L Mendosa; Adarsh M Kumar; BV Freund; C Lindsay DeVane
Sertraline in diabetic neuropathy: response and biology.
Psychosomatic medicine 2000;62(3):461-2.
2000: Dale Grothe; Karim A Calis; Leslie Jacobsen; Sanjiv Kumra; C Lindsay DeVane; Judy Rapoport; RF Bergstrom; D L Kurtz
Olanzapine pharmacokinetics in pediatric and adolescent inpatients with childhood-onset schizophrenia.
Journal of clinical psychopharmacology 2000;20(2):220-5.
2000: John S Markowitz; C Lindsay DeVane
Rifampin-induced selective serotonin reuptake inhibitor withdrawal syndrome in a patient treated with sertraline.
Journal of clinical psychopharmacology 2000;20(1):109-10.
2000: John S Markowitz; C Lindsay DeVane; David W Boulton; SW Carson; Ziad Nahas; S Craig Risch
Effect of St. John's wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteers.
Life sciences 2000;66(9):PL133-9.
2000: C Lindsay DeVane
Pharmacologic characteristics of ideal antidepressants in the 21st century.
The Journal of clinical psychiatry 2000;61 Suppl 11():4-8.
2000: Floyd R Sallee; C Lindsay DeVane; R E Ferrell
Fluoxetine-related death in a child with cytochrome P-450 2D6 genetic deficiency.
Journal of child and adolescent psychopharmacology 2000;10(1):27-34.
2000: C Lindsay DeVane; John S Markowitz
Avoiding psychotropic drug interactions in the cardiovascular patient.
Bulletin of the Menninger Clinic 2000;64(1):49-59.
1999: C Lindsay DeVane; J W Simpkins; David W Boulton; Casey Laizure; R L Miller
Disposition of morphine in tissues of the pregnant rat and foetus following single and continuous intraperitoneal administration to the mother.
The Journal of pharmacy and pharmacology 1999;51(11):1283-7.
1999: C Lindsay DeVane; MR Ware; NP Emmanuel; Olga Brawman-Mintzer; WA Morton; G Villarreal; R Bruce Lydiard
Evaluation of the efficacy, safety and physiological effects of fluvoxamine in social phobia.
International clinical psychopharmacology 1999;14(6):345-51.
1999: C Lindsay DeVane
Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors.
Cellular and molecular neurobiology 1999;19(4):443-66.
1999: PJ Goodnick; A Puig; C Lindsay DeVane; BV Freund
Mirtazapine in major depression with comorbid generalized anxiety disorder.
The Journal of clinical psychiatry 1999;60(7):446-8.
1999: Hong Zhu; Angelos Halaris; S Madakasira; PJ Pazzaglia; NH Goldman; C Lindsay DeVane; Michael Andrew; DJ Reis; John E Piletz
Effect of bupropion on immunodensity of putative imidazoline receptors on platelets of depressed patients.
Journal of psychiatric research 1999;33(4):323-33.
1999: John S Markowitz; C Lindsay DeVane
Suspected ciprofloxacin inhibition of olanzapine resulting in increased plasma concentration.
Journal of clinical psychopharmacology 1999;19(3):289-91.
1999: C Lindsay DeVane; B G Pollock
Pharmacokinetic considerations of antidepressant use in the elderly.
The Journal of clinical psychiatry 1999;60 Suppl 20():38-44.
1999: John S Markowitz; S D Morrison; C Lindsay DeVane
Drug interactions with psychostimulants.
International clinical psychopharmacology 1999;14(1):1-18.
1999: C Lindsay DeVane
No mourning for the conventional antipsychotics: the dawn of the atypical agents.
The Annals of pharmacotherapy 1999;33(1):107-8.
1998: PJ Goodnick; Roberto Dominguez; C Lindsay DeVane; Charles L Bowden
Bupropion slow-release response in depression: diagnosis and biochemistry.
Biological psychiatry 1998;44(7):629-32.
1998: C Lindsay DeVane; M Hill; E J Antal
Therapeutic drug monitoring of alprazolam in adolescents with asthma.
Therapeutic drug monitoring 1998;20(3):257-60.
1998: John S Markowitz; H S Gill; Noel M. Hunt; R R Monroe; C Lindsay DeVane
Lack of antidepressant-cyclosporine pharmacokinetic interactions.
Journal of clinical psychopharmacology 1998;18(1):91-3.
1998: C Lindsay DeVane
Differential pharmacology of newer antidepressants.
The Journal of clinical psychiatry 1998;59 Suppl 20():85-93.
1998: C Lindsay DeVane
Translational pharmacokinetics: current issues with newer antidepressants.
Depression and anxiety 1998;8 Suppl 1():64-70.
1997: H S Gill; C Lindsay DeVane; S Craig Risch
Extrapyramidal symptoms associated with cyclic antidepressant treatment: a review of the literature and consolidating hypotheses.
Journal of clinical psychopharmacology 1997;17(5):377-89.
1997: C Lindsay DeVane; John S Markowitz; Susan J. Hardesty; S Mundy; H S Gill
Fluvoxamine-induced theophylline toxicity.
The American journal of psychiatry 1997;154(9):1317-8.
1997: C Lindsay DeVane; H S Gill; John S Markowitz; William H Carson
Awareness of potential drug interactions may aid avoidance.
Therapeutic drug monitoring 1997;19(3):366-7.
1997: John S Markowitz; H S Gill; C Lindsay DeVane; Jacobo E Mintzer
Fluoroquinolone inhibition of clozapine metabolism.
The American journal of psychiatry 1997;154(6):881.
1997: C Lindsay DeVane
Rethinking treatment terminology.
The American journal of psychiatry 1997;154(5):717.
1997: C Lindsay DeVane
The place of selective serotonin reuptake inhibitors in the treatment of panic disorder.
Pharmacotherapy 1997;17(2):282-92.
1997: C Lindsay DeVane; H S Gill
Clinical pharmacokinetics of fluvoxamine: applications to dosage regimen design.
The Journal of clinical psychiatry 1997;58 Suppl 5():7-14.
1996: MR Ware; D Caton; C Lindsay DeVane
The practical use of carbon dioxide-induced anxiety in the diagnosis and care of patients with panic disorder.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 1996;8(4):199-202.
1996: John S Markowitz; H S Gill; M Lavia; T D Brewerton; C Lindsay DeVane
Fluvoxamine-clozapine dose-dependent interaction.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 1996;41(10):670-1.
1996: P A McKinney; Ryan Finkenbine; C Lindsay DeVane
Alopecia and mood stabilizer therapy.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 1996;8(3):183-5.
1996: M J Byerly; C Lindsay DeVane
Pharmacokinetics of clozapine and risperidone: a review of recent literature.
Journal of clinical psychopharmacology 1996;16(2):177-87.
1996: Charles Nemeroff; C Lindsay DeVane; Bruce G Pollock
Newer antidepressants and the cytochrome P450 system.
The American journal of psychiatry 1996;153(3):311-20.
1996: C Lindsay DeVane; Floyd R Sallee
Serotonin selective reuptake inhibitors in child and adolescent psychopharmacology: a review of published experience.
The Journal of clinical psychiatry 1996;57(2):55-66.
1996: C Lindsay DeVane
Drug interactions and antipsychotic therapy.
Pharmacotherapy 1996;16(1 Pt 2):15-20.
1995: Robert A Sweet; Bruce G Pollock; Margaret A Kirshner; B Wright; L P Altieri; C Lindsay DeVane
Pharmacokinetics of single- and multiple-dose bupropion in elderly patients with depression.
Journal of clinical pharmacology 1995;35(9):876-84.
1995: S C Tyson; C Lindsay DeVane; S C Risch
Pharmacokinetic interaction between risperidone and clozapine.
The American journal of psychiatry 1995;152(9):1401-2.
1995: Stephen E Nadeau; M W Couch; C Lindsay DeVane; S S Shukla
Regional analysis of D2 dopamine receptors in Parkinson's disease using SPECT and iodine-123-iodobenzamide.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(3):384-93.
1995: C Lindsay DeVane
Brief comparison of the pharmacokinetics and pharmacodynamics of the traditional and newer antipsychotic drugs.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 1995;52(3 Suppl 1):S15-8.
1995: C Lindsay DeVane
Pharmacokinetic and pharmacodynamic considerations for the design and screening of potential medications.
NIDA research monograph 1995;149():116-29.
1994: C Lindsay DeVane
Pharmacokinetics of the newer antidepressants: clinical relevance.
The American journal of medicine 1994;97(6A):13S-23S.
1994: C Lindsay DeVane
Pharmacogenetics and drug metabolism of newer antidepressant agents.
The Journal of clinical psychiatry 1994;55 Suppl():38-45; discussion 46-7.
1994: A S Salhab; C Lindsay DeVane; T Medrano; William C Buhi; Ian R Tebbett; Kathleen T Shiverick
Fetoplacental growth and placental protein synthesis in rats after chronic maternal cocaine administration.
The Journal of pharmacology and experimental therapeutics 1994;270(1):392-8.
1993: G M Levin; C Lindsay DeVane
Prescribing attitudes of different physician groups regarding fluoxetine.
The Annals of pharmacotherapy 1993;27(12):1443-7.
1993: J P Kemph; C Lindsay DeVane; G M Levin; R Jarecke; R L Miller
Treatment of aggressive children with clonidine: results of an open pilot study.
Journal of the American Academy of Child and Adolescent Psychiatry 1993;32(3):577-81.
1993: C Lindsay DeVane; T H Grasela; E J Antal; R L Miller
Evaluation of population pharmacokinetics in therapeutic trials. IV. Application to postmarketing surveillance.
Clinical pharmacology and therapeutics 1993;53(5):521-8.
1993: V Khot; C Lindsay DeVane; E R Korpi; D Venable; L B Bigelow; R J Wyatt; D G Kirch
The assessment and clinical implications of haloperidol acute-dose, steady-state, and withdrawal pharmacokinetics.
Journal of clinical psychopharmacology 1993;13(2):120-7.
1992: M R Ware; C Lindsay DeVane; K L Hall
Panic disorder. Recognizing and managing the 'real thing'.
Postgraduate medicine 1992;91(7):99-102, 105-8.
1992: G M Levin; C Lindsay DeVane
A review of cyclic antidepressant-induced blood dyscrasias.
The Annals of pharmacotherapy 1992;26(3):378-83.
1992: C Lindsay DeVane
Pharmacokinetics of the selective serotonin reuptake inhibitors.
The Journal of clinical psychiatry 1992;53 Suppl():13-20.
1992: William Z Potter; C Lindsay DeVane; M V Rudorfer
Steady-state predictions based on first dose data.
Clinical neuropharmacology 1992;15 Suppl 1 Pt A():239A-240A.
1991: O T Osman; C Lindsay DeVane; D J Greenblatt; William Z Potter
Pharmacokinetic and dynamic correlates of intravenous alprazolam challenge.
Clinical pharmacology and therapeutics 1991;50(6):656-62.
1991: R L Miller; C Lindsay DeVane
Determination of cocaine, benzoylecgonine and ecgonine methyl ester in plasma by reversed-phase high-performance liquid chromatography.
Journal of chromatography 1991;570(2):412-8.
1991: C Kirkwood; A Moore; P Hayes; C Lindsay DeVane; A Pelonero
Influence of menstrual cycle and gender on alprazolam pharmacokinetics.
Clinical pharmacology and therapeutics 1991;50(4):404-9.
1991: C Lindsay DeVane; C Lim; Stanley W Carson; D Tingle; L Hackett; M R Ware
Effect of electroconvulsive therapy on serum concentration of alpha-1-acid glycoprotein.
Biological psychiatry 1991;30(2):116-20.
1991: M T Pato; D L Murphy; C Lindsay DeVane
Sustained plasma concentrations of fluoxetine and/or norfluoxetine four and eight weeks after fluoxetine discontinuation.
Journal of clinical psychopharmacology 1991;11(3):224-5.
1991: David J Burchfield; V W Lucas; Robert M Abrams; R L Miller; C Lindsay DeVane
Disposition and pharmacodynamics of methamphetamine in pregnant sheep.
JAMA : the journal of the American Medical Association 1991;265(15):1968-73.
1991: C Lindsay DeVane; J W Simpkins; S A Stout
Distribution of phenobarbital and phenytoin in pregnant rats and their fetuses.
Epilepsia 1991;32(2):250-6.
1991: David J Burchfield; Robert M Abrams; R L Miller; C Lindsay DeVane
Inhalational administration of cocaine in sheep.
Life sciences 1991;48(22):2129-36.
1991: David J Burchfield; Robert M Abrams; R Miller; C Lindsay DeVane
Disposition of cocaine in pregnant sheep. II. Physiological responses.
Developmental pharmacology and therapeutics 1991;16(3):130-8.
1991: C Lindsay DeVane; David J Burchfield; Robert M Abrams; R L Miller; S B Braun
Disposition of cocaine in pregnant sheep. I. Pharmacokinetics.
Developmental pharmacology and therapeutics 1991;16(3):123-9.
1991: C Lindsay DeVane; M V Rudorfer; W Z Potter
Dosage regimen design for cyclic antidepressants: a review of pharmacokinetic methods.
Psychopharmacology bulletin 1991;27(4):619-31.
1991: J C Delafuente; C Lindsay DeVane
Immunologic effects of cocaine and related alkaloids.
Immunopharmacology and immunotoxicology 1991;13(1-2):11-23.
1991: C Lindsay DeVane
Pharmacokinetic correlates of fetal drug exposure.
NIDA research monograph 1991;114():18-36.
1991: C Lindsay DeVane; M R Ware; R B Lydiard
Pharmacokinetics, pharmacodynamics, and treatment issues of benzodiazepines: alprazolam, adinazolam, and clonazepam.
Psychopharmacology bulletin 1991;27(4):463-73.
1990: M R Ware; C Lindsay DeVane
Imipramine treatment of panic disorder during pregnancy.
The Journal of clinical psychiatry 1990;51(11):482-4.
1990: C Lindsay DeVane; Casey Laizure; J T Stewart; B E Kolts; E G Ryerson; R L Miller; A A Lai
Disposition of bupropion in healthy volunteers and subjects with alcoholic liver disease.
Journal of clinical psychopharmacology 1990;10(5):328-32.
1990: M R Ware; M L Frost; J J Berger; R B Stewart; C Lindsay DeVane
Electroconvulsive therapy complicated by insecticide ingestion.
Journal of clinical psychopharmacology 1990;10(1):72-3.
1989: C Lindsay DeVane; James W Simpkins; R L Miller; S B Braun
Tissue distribution of cocaine in the pregnant rat.
Life sciences 1989;45(14):1271-6.
1988: C S Aulakh; K M Wozniak; J L Hill; C Lindsay DeVane; Teresa Tolliver; Dennis L Murphy
Differential neuroendocrine responses to the 5-HT agonist m-chlorophenylpiperazine in Fawn-Hooded rats relative to Wistar and Sprague-Dawley rats.
Neuroendocrinology 1988;48(4):401-6.
1988: R L Miller; C Lindsay DeVane
Alprazolam, alpha-hydroxy- and 4-hydroxyalprazolam analysis in plasma by high-performance liquid chromatography.
Journal of chromatography 1988;430(1):180-6.
1987: C Lindsay DeVane
Monitoring cyclic antidepressants.
Clinics in laboratory medicine 1987;7(3):551-66.
1987: C Lindsay DeVane
Naming the cyclic antidepressants.
Journal of clinical psychopharmacology 1987;7(4):285-6.
1987: C Lindsay DeVane; J W Simpkins
Possible teratogenic effects of imipramine in the rat.
Psychopharmacology series 1987;3():174-8.
1987: S H Curry; C Lindsay DeVane; M M Wolfe
Lack of interaction of ranitidine with amitriptyline.
European journal of clinical pharmacology 1987;32(3):317-20.
1986: A K Fuller; D Tingle; C Lindsay DeVane; J A Scott; R B Stewart
Haloperidol pharmacokinetics following gastric bypass surgery.
Journal of clinical psychopharmacology 1986;6(6):376-8.
1986: R L Miller; C Lindsay DeVane
Measurement of haloperidol and reduced haloperidol in human plasma using reversed-phase high-performance liquid chromatography.
Journal of chromatography 1986;374(2):405-8.
1986: R L Miller; C Lindsay DeVane
Analysis of trazodone and m-chlorophenylpiperazine in plasma and brain tissue by high-performance liquid chromatography.
Journal of chromatography 1986;374(2):388-93.
1986: C Lindsay DeVane; Casey Laizure; D F Cameron
The effect of experimentally-induced renal failure on accumulation of bupropion and its major basic metabolites in plasma and brain of guinea pigs.
Psychopharmacology 1986;89(4):404-8.
1986: S H Curry; C Lindsay DeVane; M M Wolfe
Pharmacology of combined antidepressant/H2-blocking drug therapy.
Psychopharmacology bulletin 1986;22(1):220-2.
1985: C S Dommisse; C Lindsay DeVane; P E Hayes
Effect of estrogens on the DST.
The Journal of clinical psychiatry 1985;46(11):505.
1985: Casey Laizure; C Lindsay DeVane; J T Stewart; C S Dommisse; A A Lai
Pharmacokinetics of bupropion and its major basic metabolites in normal subjects after a single dose.
Clinical pharmacology and therapeutics 1985;38(5):586-9.
1985: C S Dommisse; C Lindsay DeVane
Buspirone: a new type of anxiolytic.
Drug intelligence & clinical pharmacy 1985;19(9):624-8.
1985: R L Yost; C Lindsay DeVane
Diurnal variation of alpha 1-acid glycoprotein concentration in normal volunteers.
Journal of pharmaceutical sciences 1985;74(7):777-9.
1985: C Lindsay DeVane; J W Simpkins
Pharmacokinetics of imipramine and its major metabolites in pregnant rats and their fetuses following a single dose.
Drug metabolism and disposition: the biological fate of chemicals 1985;13(4):438-42.
1985: L J Birklimer; C Lindsay DeVane; C E Muniz
Posttraumatic stress disorder: characteristics and pharmacological response in the veteran population.
Comprehensive psychiatry 1985;26(3):304-10.
1985: Casey Laizure; C Lindsay DeVane
Stability of bupropion and its major metabolites in human plasma.
Therapeutic drug monitoring 1985;7(4):447-50.
1985: S H Curry; C Lindsay DeVane; M M Wolfe
Cimetidine interaction with amitriptyline.
European journal of clinical pharmacology 1985;29(4):429-33.
1984: L J Birkhimer; C Lindsay DeVane
The neuroleptic malignant syndrome: presentation and treatment.
Drug intelligence & clinical pharmacy 1984;18(6):462-5.
1984: L J Birkhimer; C Lindsay DeVane; C E Muniz
Mechanism and management of important psychotherapeutic drug interactions.
Southern medical journal 1984;77(4):465-9.
1984: S A Stout; C Lindsay DeVane
Tissue assay of phenobarbital, phenytoin and p-hydroxyphenytoin by high-performance liquid chromatography.
Journal of chromatography 1984;285(3):500-8.
1984: C Lindsay DeVane; R B Stewart
Differences in diazepam and oxazepam.
Archives of general psychiatry 1984;41(3):311.
1984: C Lindsay DeVane; R D Walker; W P Sawyer; J A Wilson
Concentrations of imipramine and its metabolites during enuresis therapy.
Pediatric pharmacology (New York, N.Y.) 1984;4(4):245-51.
1984: C Lindsay DeVane; J W Simpkins; S A Stout
Cerebral and blood pharmacokinetics of imipramine and its active metabolites in the pregnant rat.
Psychopharmacology 1984;84(2):225-30.
1984: S A Stout; C Lindsay DeVane
Quantification of imipramine and its major metabolites in whole blood, brain, and other tissues of the rat by liquid chromatography.
Psychopharmacology 1984;84(1):39-41.
1984: T A Sutfin; C Lindsay DeVane; W J Jusko
The analysis and disposition of imipramine and its active metabolites in man.
Psychopharmacology 1984;82(4):310-7.
1983: Stanley W Carson; C Lindsay DeVane
Estimation of half-life and exponential decay using a nomogram.
American journal of hospital pharmacy 1983;40(10):1696-8.
1983: C Lindsay DeVane; K M Ahsanuddin
Use of psychoactive drugs in children.
Drug intelligence & clinical pharmacy 1983;17(7-8):562-4.
1983: C Lindsay DeVane; W J Jusko
Drug and metabolite concentrations combined in predicting steady-state concentrations from test doses.
Biopharmaceutics & drug disposition 1983;4(1):19-29.
1982: P R Pentel; M L Bullock; C Lindsay DeVane
Hemoperfusion for imipramine overdose: elimination of active metabolites.
Journal of toxicology. Clinical toxicology 1982;19(3):239-48.
1982: R Moskovitz; C Lindsay DeVane; R Harris; R B Stewart
Toxic hepatitis and single daily dosage imipramine therapy.
The Journal of clinical psychiatry 1982;43(4):165-6.
1982: C Lindsay DeVane; W J Jusko
Dosage regimen design.
Pharmacology & therapeutics 1982;17(2):143-63.
1981: C Lindsay DeVane; W J Jusko
Plasma concentration monitoring of hydroxylated metabolites of imipramine and desipramine.
Drug intelligence & clinical pharmacy 1981;15(4):263-6.
1981: C Lindsay DeVane; R E Wolin; R A Rovere; N C Panahon; T A Sutfin; W J Jusko
Excessive plasma concentration of tricyclic antidepressants resulting from usual doses: a report of six cases.
The Journal of clinical psychiatry 1981;42(4):143-7.
1981: C Lindsay DeVane; M Savett; W J Jusko
Desipramine and 2-hydroxy-desipramine pharmacokinetics in normal volunteers.
European journal of clinical pharmacology 1981;19(1):61-4.
1979: C Lindsay DeVane; R E Wolin; W J Jusko
Pharmacokinetic basis for predicting steady-state serum drug concentrations of imipramine from single dose data.
Communications in psychopharmacology 1979;3(5):353-7.